Drug Type Bispecific antibody |
Synonyms NVG 444, NVG-444, NVG444 |
Target |
Action modulators |
Mechanism F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia A | Discovery | United Kingdom | 01 Sep 2025 | |
| Hemophilia A | Discovery | United Kingdom | 01 Sep 2025 |






